Review highlights how chemical epigenetic modifiers boost alkaloid production in medicinal plants, indicating new strategies for enhancement.
Epigenetic regulation plays a significant role in controlling plant secondary metabolism and offers a promising strategy to enhance medicinal alkaloid production without altering the genomic sequence. This review highlights major plant epigenetic mechanisms, including DNA methylation, histone modifications, chromatin remodeling, and non-coding RNAs, and their influence on alkaloid biosynthetic pathways. Particular emphasis is placed on chemical epigenetic modulators, such as DNA methyltransferase and histone deacetylase inhibitors, which can activate silent metabolic genes in a rapid, reversible, and non-GMO manner. Evidence from medicinal plants demonstrates tissue-, dose-, and time-dependent enhancement of alkaloid production. The review further discusses emerging approaches including CRISPR-based epigenome editing, multi-omics integration, and advanced bioinformatics for systems-level understanding of epigenetic regulation. Despite challenges, such as limited species-specific datasets, and concerns regarding long-term stability, epigenetic modulation represents a promising tool for sustainable alkaloid production with important pharmaceutical and industrial applications.
No takes yet. Share an insight, caveat, or question.
Devi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: